Application of membrane-active peptides for nonviral gene delivery

被引:154
作者
Wagner, E [1 ]
机构
[1] Univ Vienna, Bioctr, Inst Biochem, A-1030 Vienna, Austria
关键词
polylysine; polyethylenimine; receptor-mediated gene transfer; endosomal release; amphipathic peptides; transfection;
D O I
10.1016/S0169-409X(99)00033-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A variety of membrane-modifying agents including pH-specific fusogenic or lytic peptides, bacterial proteins, lipids, glycerol, or inactivated virus particles have been evaluated for the enhancement of DNA-polycation complex-based gene transfer. The enhancement depends on the characteristics of both the cationic carrier for DNA and the membrane-modifying agent. Peptides derived from viral sequences such as the N-terminus of influenza virus haemagglutinin HA-2, the N-terminus of rhinovirus HRV2 VP-1 protein, and other synthetic or natural sequences such as the amphipathic peptides GALA, KALA, EGLA JTS1, or gramicidin S have been tested. Ligand-polylysine-mediated gene transfer can be improved up to more than 1000-fold by membrane-active compounds. Other polycations like dendrimers or polyethylenimines as well as several cationic lipids provide a high transfection efficiency per se. Systems based on these polymers or lipids are only slightly enhanced by endosomolytic peptides or adenoviruses. Electroneutral cationic lipid-DNA complexes however can be strongly improved by the addition of membrane-active peptides, (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:279 / 289
页数:11
相关论文
共 94 条